IPL continues to suffer from inventory overhang in global markets, and have pivoted towards selling more formulations in India. They announced setting up a marketing co for formulations in export market, something similar to Sharda Cropchem. Concall notes below
FY24Q2
- Inventory loss of 6 cr. in Q2
- Pesticides I didn’t know they make
o Fungicides: Etridiazole, Dodine
o Insecticides: Diafenthiuron
o Herbicide: Flufenacet - Industry scenario: Continues to face headwinds due to destocking in international markets and price declines resulting from oversupply of raw materials from China
- Domestic formulation: 15-18% EBITDA margin. Export formulation is higher margin but volumes are very low
- LATAM: don’t have direct subsidiary but are present through partners (8-10% revenue contribution)
- Company is planning to setup a subsidiary for marketing formulation in export market in an asset light business model (something similar to Sharda Cropchem)
- For new products, want to maintain 20-22% EBITDA margin & 43-44% gross margin
- Prosulfocarb: very high inventory in end market resulting in volume pressure for IPL
- Expansion
o Intermediate block and technical block will be commercialized in Q4FY24. Will augment production capacity by ~2000 MT
o Acquired land adjacent to Sandila plant for future expansion
o Have spent 46 cr. in H1FY24 (budget of 110 cr. for Sandila + Hamirpur)
Disclosure: Not invested (no transactions in last-30 days)
Subscribe To Our Free Newsletter |